Table 2 Subjects With a Vaccine Response and rSBA GMTs After the MenACWY-TT Booster Dose
Vaccine Response,a % (CI) | GMT, % (CI) | ||
|---|---|---|---|
1 Month After MenACWY-TT Booster | Before MenACWY-TT Booster | 1 Month After MenACWY-TT Booster | |
Serogroup A | |||
Primary MenACWY-TT (n = 155) | 87.7 (81.5, 92.5) | 153.8 (108.1, 218.6) | 4059.5 (3383.8, 4870.2) |
Primary MenACWY-PS (n = 52) | 88.5 (76.6, 95.6) | 75.1 (41.4, 136.4) | 3584.8 (2750.7, 4672.0) |
Serogroup C | |||
Primary MenACWY-TT (n = 154) | 90.9 (85.2, 94.9) | 192.8 (140.6, 264.4) | 13,823.5 (10,839.7, 17,628.7) |
Primary MenACWY-PS (n = 52) | 75.0 (61.1, 86.0) | 212.4 (109.6, 411.8) | 3444.3 (1998.5, 5936.0) |
Serogroup W | |||
Primary MenACWY-TT (n = 154) | 94.2 (89.2, 97.3) | 166.2 (107.1, 257.9) | 24,431.0 (17,351.4, 31,640.7) |
Primary MenACWY-PS (n = 52) | 96.2 (86.8, 99.5) | 10.9 (6.1, 19.3) | 5792.6 (3585.9, 9357.4) |
Serogroup Y | |||
Primary MenACWY-TT (n = 154) | 83.8 (77.0, 89.2) | 363.7 (254.6, 519.4) | 8958.4 (7601.6, 10,557.5) |
Primary MenACWY-PS (n = 52) | 92.3 (81.5, 97.9) | 56.0 (28.8, 109.1) | 5137.8 (3528.2, 7481.6) |